SAB Biotherapeutics, Inc. (SABS): 424B3 filed Aug 21, 2026

Form type

424B3

Filing date

Aug 21, 2026

Accession number

0001193125-26-361180

Filer

SAB Biotherapeutics, Inc. (CIK 1833214)